You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 23, 2025

Details for Patent: 11,241,422


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,241,422 protect, and when does it expire?

Patent 11,241,422 protects GALAFOLD and is included in one NDA.

This patent has forty-one patent family members in seventeen countries.

Summary for Patent: 11,241,422
Title:Methods for treatment of Fabry disease
Abstract:Provided are in vitro and in vivo methods for determining whether a patient with Fabry disease will respond to treatment with a specific pharmacological chaperone.
Inventor(s):David J. Lockhart, Jeff Castelli
Assignee:Bpcr LP, Amicus Therapeutics Inc
Application Number:US16/564,694
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 11,241,422

Introduction to U.S. Patents

U.S. patents are granted by the United States Patent and Trademark Office (USPTO) and are a crucial component of intellectual property law. The Leahy-Smith America Invents Act (AIA) of 2011 significantly altered the U.S. patent landscape, introducing new procedures such as the Patent Trial and Appeal Board (PTAB) and Inter Partes Review[1].

The Importance of Patent Claims

Patent claims are the heart of any patent application, as they define the scope of the invention for which protection is sought. Under 35 U.S.C. ยง 112, patent claims must "particularly point out and distinctly claim the subject matter which the applicant regards as his invention"[2].

Key Requirements for Patent Claims

Novelty Requirement

For a patent to be granted, the claimed invention must be novel, meaning it must not have been patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention[1].

Nonobviousness Requirement

The invention must also be nonobvious, meaning it must not be obvious to a person having ordinary skill in the relevant field at the time of the invention. This requirement ensures that the invention is a significant advancement over existing knowledge[1].

Indefiniteness

Patent claims must be definite, meaning they must inform those skilled in the art about the scope of the invention with reasonable certainty. Claims that are indefinite because they fail to meet this requirement can be invalidated[2].

Measuring Patent Scope

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. These metrics can indicate the breadth and clarity of the patent claims. For instance, narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Analyzing United States Patent 11,241,422

To analyze the scope and claims of United States Patent 11,241,422, one must delve into the specifics of the patent document.

Patent Title and Abstract

The title and abstract provide a preliminary understanding of the invention. For example, if the patent is related to a technological innovation, the abstract will outline the key features and benefits of the invention.

Claims Section

The claims section is where the patentee defines the invention. Here, you will find independent and dependent claims that delineate the scope of the invention. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide additional details.

Description and Drawings

The detailed description and drawings section provides a comprehensive explanation of the invention, including how it works and its various components. This section helps in understanding the context and scope of the claims.

Example Analysis

Let's consider a hypothetical example similar to what might be found in a patent like 11,241,422:

  • Independent Claim 1: "A rechargeable lithium-ion battery comprising at least two lithium-containing transition metal oxides, represented by specific formulas."
  • Dependent Claim 2: "The rechargeable lithium-ion battery of claim 1, wherein the transition metal oxides are selected from a group consisting of nickel, cobalt, and manganese."

In this example, the independent claim defines the broad scope of the invention, while the dependent claim narrows it down by specifying particular transition metal oxides.

Challenges and Reviews

Patents can face challenges through various mechanisms, including Inter Partes Review (IPR) before the PTAB. These reviews can question the validity of the patent based on prior art, novelty, nonobviousness, and other grounds[1].

Global Patent Landscape

The global patent landscape is increasingly interconnected. Tools like the Global Dossier and Common Citation Document (CCD) facilitate the integration of patent information across different jurisdictions, making it easier to track and analyze patent families and prior art[4].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address the high costs and complexities associated with patent litigation. Such a court could provide a more streamlined and cost-effective way for small inventors and businesses to resolve patent disputes[5].

Key Takeaways

  • Patent Claims: The core of a patent application, defining the scope of the invention.
  • Novelty and Nonobviousness: Fundamental requirements for patentability.
  • Indefiniteness: Claims must be clear and definite to be valid.
  • Patent Scope Metrics: Independent claim length and count can measure patent breadth.
  • Global Integration: Tools like Global Dossier and CCD facilitate international patent analysis.
  • Challenges and Reviews: Mechanisms like IPR ensure the validity of patents.

FAQs

Q1: What is the role of the Patent Trial and Appeal Board (PTAB)? The PTAB is a tribunal within the USPTO that hears administrative challenges to the validity of patents, including Inter Partes Review[1].

Q2: How do you measure the scope of a patent? The scope of a patent can be measured using metrics such as independent claim length and independent claim count, which can indicate the breadth and clarity of the patent claims[3].

Q3: What is the significance of the Leahy-Smith America Invents Act (AIA)? The AIA is the most significant patent statute enacted by Congress in over 50 years, introducing new procedures like PTAB and Inter Partes Review[1].

Q4: Why is indefiniteness a critical issue in patent claims? Indefiniteness can lead to the invalidation of patent claims because they must inform those skilled in the art about the scope of the invention with reasonable certainty[2].

Q5: How does the Global Dossier facilitate patent analysis? The Global Dossier provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family, classification, and citation data for these applications[4].

Sources

  1. Congressional Research Service, "The Patent Trial and Appeal Board and Inter Partes Review," Updated May 28, 2024.
  2. United States Court of Appeals for the Federal Circuit, "MAXELL, LTD. v. AMPEREX TECHNOLOGY LIMITED," March 6, 2024.
  3. SSRN, "Patent Claims and Patent Scope," September 29, 2016.
  4. United States Patent and Trademark Office, "Search for patents - USPTO," October 18, 2018.
  5. Administrative Conference of the United States, "U.S. Patent Small Claims Court," April 28, 2022.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,241,422

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Amicus Therap Us GALAFOLD migalastat hydrochloride CAPSULE;ORAL 208623-001 Aug 10, 2018 RX Yes Yes 11,241,422 ⤷  Try for Free THE TREATMENT OF FABRY PATIENTS ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,241,422

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2787345 ⤷  Try for Free 300843 Netherlands ⤷  Try for Free
European Patent Office 2787345 ⤷  Try for Free PA2016033 Lithuania ⤷  Try for Free
European Patent Office 2787345 ⤷  Try for Free 122016000090 Germany ⤷  Try for Free
European Patent Office 2787345 ⤷  Try for Free CA 2016 00055 Denmark ⤷  Try for Free
European Patent Office 2787345 ⤷  Try for Free 93312 Luxembourg ⤷  Try for Free
European Patent Office 2787345 ⤷  Try for Free C20160037 00206 Estonia ⤷  Try for Free
European Patent Office 2787345 ⤷  Try for Free 16C1014 France ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.